NCT05591768

Brief Summary

This is a prospective randomized controlled trial study will aim to evaluate the the efficacy and procedural pain of BRFA and to compare it with conventional technique (MRFA). And to compare the complications and time taken to complete the procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 24, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

November 14, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

August 6, 2026

Status Verified

October 1, 2022

Enrollment Period

1.2 years

First QC Date

August 18, 2022

Last Update Submit

August 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy and procedural pain

    Is to evaluate the efficacy and procedural pain of BRFA and to compare it with conventional technique (MRFA) by questionnaire participants

    Baseline

Secondary Outcomes (1)

  • Knee pain and function

    2 years

Study Arms (2)

MBA group monopolar radiofrequency group.

EXPERIMENTAL

Inferomedial, superomedial, superolateral GN branches and nerve to vastus intermediate of the patients were identified with fluoroscopy, and a 22 Gauge, 10 cm radiofrequency (RF) cannula with a 10 mm active tip was advanced to the targeted nerves under fluoroscopy guidance. The location of the RF cannula was visualized by anteriorposterior and lateral images. Sensory stimulation was applied at 50 Hz to determine the nerve position. Since the sensory stimulation threshold must be \< 0.6 V, nerve position was tested with the absence of fasciculation in the relevant area of the lower extremity upon 2.0 V stimulation at 2 Hz.

Procedure: Monopolar radiofrequency

BFA group bipolar radiofrequency group

EXPERIMENTAL

similar technique will be used to insert the canula, except that, instead of one cannula two cannulae (approximately 10 mm apart) apart) will be inserted and no manipulation of cannulae was done to stimulate the target nerve as done in MRFA Target areas were similar to monopolar technique Each nerve will be ablated for 2 minutes in both the groups. All procedures were done by one pain physician who had more then 10 years' experience of radiofrequency procedures

Procedure: Bipolar radiofrequency

Interventions

In monopolar group : . Inferomedial, superomedial, superolateral GN branches and nerve to vastus intermedius of the patients were identified with fluoroscopy and a 22 Gauge, 10 cm radiofrequency (RF) cannula with a 10 mm active tip was advanced to the targeted nerves under fluoroscopy guidance. The location of the RF cannula was visualized by anteriorposterior and lateral images. Sensory stimulation was applied at 50 Hz to determine the nerve position. Since the sensory stimulation threshold must be \< 0.6 V, nerve position was tested with the absence of fasciculation in the relevant area of the lower extremity upon 2.0 V stimulation at 2 Hz.

MBA group monopolar radiofrequency group.

a similar technique will be used to insert the canula, except that, instead of one cannula two cannulae (approximately 10 mm apart) apart) will be inserted and no manipulation of cannulae was done to stimulate the target nerve as done in MRFA Target areas were similar to monopolar technique Each nerve will be ablated for 2 minutes in both the groups. All procedures were done by one pain physician who had more then 10 years' experience of radiofrequency procedures.

BFA group bipolar radiofrequency group

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • (1) outpatient clinic with osteoarthritis-character chronic knee pain, OA grades II-IV (Kellgren and Lawrence scale).
  • (2) Patients not responding to other treatments as physiotherapy, oral analgesics, and intraarticular injection with hyaluronic acids or steroids.
  • (3) Patients refused surgery. (4) Patients after failed conservative treatment for 3 months and reported more than 50% pain relief after diagnostic genicular nerve block with 2% of 2 mL lidocaine on superior lateral, superior medial and inferior medial genicular nerves.

You may not qualify if:

  • Patients with acute knee pain, previous knee surgery, other connective tissue disorders affecting the knee.
  • serious neurologic or psychiatric disorders, those had previously received radiofrequency ablation therapy for similar symptoms.
  • contraindications for genicular nerve block or genicular nerve RF (active infection, bleeding disorders, current use of anticoagulants or antiplatelets, allergy against the drugs used during the protocol, pregnancy, cardiac pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit University hospitals

Asyut, Egypt

Location

Related Publications (2)

  • Choi WJ, Hwang SJ, Song JG, Leem JG, Kang YU, Park PH, Shin JW. Radiofrequency treatment relieves chronic knee osteoarthritis pain: a double-blind randomized controlled trial. Pain. 2011 Mar;152(3):481-487. doi: 10.1016/j.pain.2010.09.029. Epub 2010 Nov 4.

  • Protzman NM, Gyi J, Malhotra AD, Kooch JE. Examining the feasibility of radiofrequency treatment for chronic knee pain after total knee arthroplasty. PM R. 2014 Apr;6(4):373-6. doi: 10.1016/j.pmrj.2013.10.003. Epub 2013 Dec 27.

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Hany Ahmed ibrahim, Professor

    Assiut University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigatr

Study Record Dates

First Submitted

August 18, 2022

First Posted

October 24, 2022

Study Start

November 14, 2022

Primary Completion

February 1, 2024

Study Completion

June 1, 2024

Last Updated

August 6, 2026

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations